申请人:The DuPont Merck Pharmaceutical Company
公开号:US05696119A1
公开(公告)日:1997-12-09
This invention relates to (2-quinoxalinyloxy)phenoxypropanoic acids, related derivatives thereof, enantiomeric and diastereomeric forms thereof, mixtures of enantiomeric diastereomeric forms thereof, and pharmaceutically acceptable salt forms thereof, pharmaceutical compositions containing them, processes for their preparation, and methods of using them to treat cancer, particularly solid tumors, in mammals.
该发明涉及(2-喹喹啉氧基)苯氧丙酸及其相关衍生物、对映异构体和顺反异构体形式、对映异构体和顺反异构体形式的混合物、以及其药学上可接受的盐形式、包含它们的制药组合物、制备它们的工艺以及使用它们治疗哺乳动物尤其是实体瘤癌的方法。